Oxaliplatin-desensitization procedure is safe and feasible in an outpatient cancer unit in France
| Autor: | Elise Lepoix, Camille Mazza, Florian Slimano, Damien Botsen, Anne Grange, Olivier Bouché, Mathilde Brasseur |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
Adult
Male medicine.medical_specialty medicine.medical_treatment Pain medicine Routine practice Medical Oncology Drug Hypersensitivity 03 medical and health sciences 0302 clinical medicine Neoplasms Outpatients medicine Humans 030212 general & internal medicine Aged Gastrointestinal Neoplasms Retrospective Studies Desensitization (medicine) Aged 80 and over Inpatients business.industry Nursing research Middle Aged Oxaliplatin Hospitalization Oncology Desensitization Immunologic 030220 oncology & carcinogenesis Emergency medicine Ambulatory Quality of Life Female France business medicine.drug |
| Zdroj: | Supportive Care in Cancer. 27:3179-3182 |
| ISSN: | 1433-7339 0941-4355 |
| Popis: | This study was undertaken to assess the previously unevaluated safety and feasibility of oxaliplatin-desensitization procedure add a French ambulatory cancer unit, which is a current topic in oncology. Our findings demonstrated that oxaliplatin-desensitization was safe and feasible in our ambulatory cancer unit. In routine practice, all these procedures are done on an inpatient basis starting at least the day before. Those results could change oncological practices in France and improve patients' quality of life and lower costs associated with inpatient administration. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink